RAEDYONT

What this means for you

Not registered yet, but its 25 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97090507

Mark type

Stylized text

Filed

25 Oct 2021

Published for opposition

21 Feb 2023

Attorney of record

Maury M. Tepper, III

Goods and services

• Class 005 — Pharmaceuticals: Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Owner

• Novartis AG, Basel, CH
• Novartis AG, Basel, CH

Prosecution history

• 16 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 16 Mar 2026 — SOU EXTENSION 5 GRANTED
• 14 Oct 2025 — SOU EXTENSION 5 FILED
• 13 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 15 Oct 2025 — SOU TEAS EXTENSION RECEIVED
• 14 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 13 Apr 2025 — SOU EXTENSION 4 GRANTED
• 13 Apr 2025 — SOU EXTENSION 4 FILED
• 13 Apr 2025 — SOU TEAS EXTENSION RECEIVED
• 14 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 14 Oct 2024 — SOU EXTENSION 3 GRANTED
• 14 Oct 2024 — SOU EXTENSION 3 FILED
• 14 Oct 2024 — SOU TEAS EXTENSION RECEIVED
• 02 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Mar 2024 — SOU EXTENSION 2 GRANTED